ACE and myocarditis: NSAID use may also counteract the beneficial mechanisms of angiotensin-converting enzyme inhibitors (ACEi)/angiotensin II receptor blocker (ARB) therapy seen in chronic heart failure management, further supporting careful and judicious NSAID use in myocarditis, particularly in the absence of pericardial inflammation and effusion [13].